Objective To help to clarify whether long term use of proton pump inhibitors is associated with an increased risk of gastric adenocarcinoma by designing a study that considered the existing literature ...

PolyPEPI1018 Cancer Vaccine and TAS-102 for Patients With Advanced, Chemo-Refractory, Microsatellite-Stable Metastatic Colorectal Cancer: A Phase Ib Nonrandomized Study Using SEER 22 data, we analyzed ...

Study should "offer relief" to patients who need long-term therapy for acid-related disord ...

Please provide your email address to receive an email when new articles are posted on . The addition of sintilimab to first-line chemotherapy extended OS among patients with advanced or metastatic ...

Sources of error that may lead to false association include PPI use shortly before diagnosis, short-term PPI use.

Physical Activity in Stage III Colon Cancer: CALGB/SWOG 80702 (Alliance) Between October 2019 and June 2021, 32 patients with dMMR/MSI-H gastric/GEJ adenocarcinoma were enrolled. The median age was 65 ...

Vyloy, a CLDN18.2-directed antibody, is approved for HER2-negative gastric or GEJ adenocarcinoma with CLDN18.2-positive tumors. The Ventana CLDN18 (43-14A) RxDx Assay identifies patients eligible for ...

Patients with ECOG performance status of 1 reported worse global health status, quality of life, and physical functioning than those with a status of 0. The RATIONALE-305 trial showed Tevimbra plus ...

While heartburn medication can be a lifesaver for those suffering from gastric reflux, several studies over the years have ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. The addition of nivolumab to chemotherapy showed durable ...